As the COVID-19 pandemic continues to spread, all countries, including Canada, are scrambling to acquire the needed resources to treat patients and to protect front-line healthcare workers. In response, XCO, through an accelerated R&D program with international partners, is developing...
News
XCO Tech Inc. welcomes Natalie Arseneau as VP Marketing
Penticton, BC – June 5th, 2019 – XCO Tech Inc. is pleased to announce the addition of Natalie Arseneau as Vice President, Marketing. Natalie will start immediately in the role and will have responsibility for the company's marketing and communication strategy. XCO Tech Inc....
Precision Medicine - Precise and Personal
Every one of us is unique, we have a unique combination of genes, live in unique environments and have unique experiences. In medicine, such patient to patient variability pose formidable challenges to clinicians as they strive to accurately assess injuries...
Strategic Innovation Fund Round 2
Earlier this year, we submitted an application for funding through the federal Strategic Innovation Fund program. Our proposal, leading a consortium of major companies, academic institutions and independent researchers, leverages the capabilities we're bringing to market in our XPSTM BioAnalyticsTM platform. The...
XCO receives $800,000 WINN funding
XCO Tech Inc. is developing breakthrough products for sport performance training and concussion assessment using its proprietary technology that provides insightful digital biomarkers to better guide training, rehabilitation and treatment. The commercial promise of XCO Tech Inc.’s innovative technology that...